Similar articles

• Management of dyslipidemia.

  Akel MM, Salti I. Akel MM, et al. J Med Liban. 2001 Sep-Oct;49(5):274-8. J Med Liban. 2001. PMID: 12243421 No abstract available.
• [Diabetic dyslipidemia: which target levels and treatment options exist for diabetics?].

  Broedl UC, Lehrke M, Parhofer KG. Broedl UC, et al. MMW Fortschr Med. 2008 Jun 19;150(25):41-3. MMW Fortschr Med. 2008. PMID: 18705054 German. No abstract available.
• [Diagnosis and treatment of hyperlipoproteinemias].

  Hauser J, Pometta D. Hauser J, et al. Schweiz Med Wochenschr. 1972 Feb 26;102(8):265-70. Schweiz Med Wochenschr. 1972. PMID: 5010516 French. No abstract available.
• The use of lipid-lowering agents in HIV-infected patients.

  Meienberg F, Battegay E, Bucher HC, Battegay M. Meienberg F, et al. J HIV Ther. 2001 May;6(2):40-4. J HIV Ther. 2001. PMID: 11501203 Review. No abstract available.
• [Treatment of dyslipidemias and its benefits].

  Taskinen MR. Taskinen MR. Duodecim. 1999;115(10):1138-44. Duodecim. 1999. PMID: 11877853 Review. Finnish. No abstract available.